Pancreatic cancer cell migration in vitro was reduced by the combination treatment of Vactosertib and T1-44 and TGF-β-induced migration was also blocked by the combination treatment (Fig. 3F, Supplementary Fig. S4). This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.